AVEO Pharmaceuticals, Inc. to Present at Upcoming Investment Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- AVEO Pharmaceuticals, Inc. (AVEO) today announced that the companys management will present a company overview at upcoming investment conferences.
Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Deutsche Bank 37th Annual Health Care Conference on Tuesday, May 8, 2012 at 3:30 p.m. (ET) at the InterContinental Hotel in Boston.
David Johnston, chief financial officer, is scheduled to present at the 2012 BofA Merrill Lynch Health Care Conference on Thursday, May 17, 2012 at 12:00 p.m. (PT) at Encore at the Wynn Las Vegas.
Webcasts of AVEOs presentations can be accessed by visiting the investors section of the companys website at investor.aveopharma.com. A replay of the webcasts will be archived on the AVEO website for two weeks following each presentation date, respectively.
AVEO Pharmaceuticals is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients lives. AVEOs proprietary Human Response Platform" provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the companys website at www.aveopharma.com.
AVEO Pharmaceuticals, Inc.
Monique Allaire, 617-299-5810
Rob Kloppenburg, 617-299-5655
Source: AVEO Pharmaceuticals, Inc.Copyright Business Wire 2012